DOCSLIB.ORG

Structural Basis for Human Sterol Isomerase in Cholesterol Biosynthesis and Multidrug Recognition

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Structural Basis for Human Sterol Isomerase in Cholesterol Biosynthesis and Multidrug Recognition ARTICLE https://doi.org/10.1038/s41467-019-10279-w OPEN Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition Tao Long 1, Abdirahman Hassan 1, Bonne M Thompson2, Jeffrey G McDonald1,2, Jiawei Wang3 & Xiaochun Li 1,4 3-β-hydroxysteroid-Δ8, Δ7-isomerase, known as Emopamil-Binding Protein (EBP), is an endoplasmic reticulum membrane protein involved in cholesterol biosynthesis, autophagy, 1234567890():,; oligodendrocyte formation. The mutation on EBP can cause Conradi-Hunermann syndrome, an inborn error. Interestingly, EBP binds an abundance of structurally diverse pharmacolo- gically active compounds, causing drug resistance. Here, we report two crystal structures of human EBP, one in complex with the anti-breast cancer drug tamoxifen and the other in complex with the cholesterol biosynthesis inhibitor U18666A. EBP adopts an unreported fold involving five transmembrane-helices (TMs) that creates a membrane cavity presenting a pharmacological binding site that accommodates multiple different ligands. The compounds exploit their positively-charged amine group to mimic the carbocationic sterol intermediate. Mutagenesis studies on specific residues abolish the isomerase activity and decrease the multidrug binding capacity. This work reveals the catalytic mechanism of EBP-mediated isomerization in cholesterol biosynthesis and how this protein may act as a multi-drug binder. 1 Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. 2 Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. 3 State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China. 4 Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Correspondence and requests for materials should be addressed to X.L. (email: [email protected]) NATURE COMMUNICATIONS | (2019) 10:2452 | https://doi.org/10.1038/s41467-019-10279-w | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10279-w holesterol maintains membrane structure, is a precursor shown to cause the death of cancer cells by influencing cholesterol Cin the biosynthesis of steroid hormones and bile acid, metabolism17,18. and has various roles in cell signaling. Acetyl-CoA, the Bioinformatics analysis shows that EBP shares structural fea- precursor of cholesterol biosynthesis, is converted into lanos- tures with both the membrane protein TM6SF2, which is asso- 19 terol, the first sterol-like intermediate, through a series of ciated with nonalcoholic fatty liver disease , and the σ2 receptor, reactions in the endoplasmic reticulum1–3. Due to its low which is highly expressed in multiple types of cancer cells20,21. solubility, lanosterol is handled by a number of membrane Here we present two structures of human EBP protein each in enzymes and is eventually converted to cholesterol4–6 (Sup- complex with a different pharmacologically active compound, plementary Fig. 1). To date, among those membrane enzymes revealing its mechanism of action in cholesterol biosynthesis and only the structure of sterol C14-demethylaase7 (CYP51) and the multidrug recognition. homolog of Δ14-sterol reductase4 have been determined. EBP catalyzes the conversion of Δ8-sterols (e.g zymosterol and Results zymostenol) to their corresponding Δ7-isomers (Fig. 1a). Functional characterization. To validate the function of EBP, the Mutations in EBP can lead to Conradi–Hunermann syndrome, human EBP-encoding plasmid was transferred to a yeast sterol which commonly causes growth deficiency, short stature, and isomerase erg2 knockout strain22 (Fig. 1b). The expression of curvature of the spine8. human EBP, but not the vector alone, allowed the yeast to survive Inhibition of EBP causes an accumulation of its sub- under exposure to 50 ng/ml cycloheximide, suggesting that strates zymosterol and zymostenol, contributing to autophagy in human EBP functions as a sterol isomerase in this system tumor cells9,10 and oligodendrocyte formation in the central (Fig. 1b). However, when we supplemented the medium with nervous system11. Notably, EBP binds an abundance of structu- either U18666A (an inhibitor of cholesterol biosynthesis and rally diverse pharmacologically active compounds, including Niemann-Pick C1 protein)23,24 or tamoxifen (Fig. 1c), growth of antidepressants, antipsychotics, opioid analgesics, sterol bio- – the yeast was inhibited (Fig. 1b). Our competition binding assay synthesis inhibitors and anti-tumor reagents12 14 (Supplementary shows that either U18666A or tamoxifen can compete with the Fig. 2). This type of broad specificity is similar to the σ1 receptor [3H]-Ifenprodil binding of purified EBP in vitro12 (Fig. 1d). This that has been linked to a wide variety of signal transduction observation is consistent with a previous ligand-binding study in pathways15, although the sequence analysis shows that EBP and the yeast microsome12, suggesting that these compounds may σ1 receptor share no structural similarity. Remarkably, as a bind the catalytic site of EBP to block enzymatic activity. component of the microsomal anti-estrogen-binding site (AEBS), which is involved in estrogen receptor-independent effects of tamoxifen, EBP can lower the availability of intracellular The overall structure. The purified EBP protein presented a tamoxifen, causing resistance16. Some EBP ligands have been monodisperse peak on gel filtration encouraging us to continue a c O R R R 9 8 + 8 N 7 ON U18666AU18 HO HO HO Δ8-sterol Carbocationic intermediate Δ7-isomer R= R= N Zymosterol Zymostenol Dehydrolathosterol Lathosterol ON Tamoxifen b d HO erg2 N H3 [H3]-Ifenprodil 9 8 3 7 HO H HO HO 7000 Tamoxifen IC = 165 ± 13 nM Fecosterol Episterol 50 ± 6000 U18666A IC50 = 351 12 nM Input 5000 EV 4000 WT 3000 EV + 50 μM Tamoxifen WT 2000 ]-Ifenprodil binding (CPM) 3 H EV [ 1000 +100 μM U18666A WT 0 Without +50 ng/ml –10 –9 –8 –7 –6 –5 –4 –3 cycloheximide cycloheximide Log[ligand](M) Fig. 1 Functional characterization of human EBP protein. a Reaction catalyzed by human EBP in which zymosterol (Δ8-sterol) is converted to dehydrolathosterol (Δ7-sterol). b Yeast complementation assay. EBP can rescue the growth of a Saccharomyces cerevisiae sterol isomerase Erg2 (yeast EBP homologue) deletion strain (ΔErg2). Growth of yeast expressing human EBP in the presence of sub-inhibitory concentrations of cycloheximide for 24 to 48 h with or without pharmacological compound. c The structures of U18666A and tamoxifen. d The binding of EBP to different ligands. Inhibition of [3H]- Ifenprodil binding to the purified EBP protein by U18666A (red) and tamoxifen (black). Data shown are the mean ± SD of three determinations. Source data are provided as a Source Data file. EV empty vector, WT wild type 2 NATURE COMMUNICATIONS | (2019) 10:2452 | https://doi.org/10.1038/s41467-019-10279-w | www.nature.com/naturecommunications NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10279-w ARTICLE a b TM5 Cytosol TM4 TM3 TM5 U18666A TM2 TM1 90° TM4 H1 U18666A TM2 TM1 H1 Lumen TM3 65 Å c d TM5 Cytosol TM4 TM3 Tamoxifen TM1 TM4 TM2 90° H1 TM2 Tamoxifen TM1 H1 TM3 Lumen e f U18666A Tamoxifen Tamoxifen –5 kT/e 5 kT/e Fig. 2 Molecular architecture of human EBP. a Overall structure of EBP with U18666A viewed parallel to the membrane. Each molecule of the dimer is indicated in the different colors. The two lines show the approximate location of the lipid bilayer. b The bottom view of EBP with U18666A from the lumen. c Overall structure of EBP with tamoxifen viewed parallel to the membrane. d The bottom view of EBP with tamoxifen from the lumen. e Electrostatic surface representation of EBP and the ligand-biding site with tamoxifen. f, 2Fo – Fc map for U18666A and tamoxifen (blue mesh) contoured at 1σ with our structural investigation (Supplementary Fig. 3). Crystals Tactin sepharose (Supplementary Fig. 7a), implying that EBP can were only obtained with U18666A or tamoxifen in space group form a dimer as shown by our structural observation. Mutations Δ P21212, owing to these two compounds presenting a high binding in the dimer interface lead to slower growth of the Erg2 affinity to EBP (Supplementary Fig. 2). The structure was deter- Saccharomyces cerevisiae at exposure of 50 ng/ml cycloheximide mined by selenium-based single-wavelength anomalous disper- (Supplementary Fig. 7b, c), implying that the dimerization may sion (SAD) and refined at 3.2 Å resolution with U18666A and play a role in fully activating EBP. Notably, sequence analysis 3.5 Å resolution with tamoxifen (Supplementary Figs. 4, 5 and suggests that the TM6SF2 protein contains two repeat units, each Supplementary Table 1). This protein contains five transmem- of which shares sequence homology with EBP21. brane helices (TMs 1–5) (Fig. 2a–e). Based on the previous immunoblotting study25 and positive inside rule26, we assigned the N-terminal face to the lumen (Fig. 2a, b). In the density map, The horizontal helix linker. A linker between TM2 and TM3 the ligand (U18666A or tamoxifen) was determined unambigu- forms a membrane horizontal helix (H1) that blocks a hydro- ously (Fig. 2f). Comparison between U18666A-bound and phobic cavity created by the residues of TMs 2–5(Fig.2a–d). tamoxifen-bound structures revealed a similar conformation The residues of H1, which face the cavity, are hydrophobic and (Supplementary Fig. 6). aromatic (Fig. 3a, b and Supplementary Fig. 8), while the A DALI search for structural homologues failed to identify a residues facing the lumen are hydrophilic. Importantly, Ala similar entry for the entire structure, implying that EBP presents substitutions of Trp101, Tyr104 and Tyr111, which face the an unreported fold. EBP forms a homodimer in the crystal, as hydrophobic cavity, abolish over 90% of the isomerase activity reported in previous solution studies27, with dimensions of 65 × by gas chromatography analysis28. Conversion of Δ8-sterols to 30 × 55 Å. The area of the dimer interface including TMs 3–5of Δ7-isomers occurs through the uptake of solvent hydrogen from each monomer is 1460 Å2 (Fig.
Load more

Recommended publications
  • Exploring Novel Estrogen Receptors
    ExploringExploring novelnovel estrogenestrogen receptorsreceptors and How many drug targets? What are the relevant drug metabolizing enzymes? Tudor I. Oprea UNM Division of Biocomputing NMNM MLSCMLSC http://screening.health.unm.edu/ Support: New Mexico Molecular Libraries Screening Center (NIH MH074425) Strasbourg Summer School on Cheminformatics Obernai, Alsace, France, June 23 2008 The University of New Mexico ♦ Health Sciences Center Copyright © Tudor I. Oprea, 2007. All rights reserved SCHOOL OF MEDICINE MLIMLI inin NumbersNumbers NIHNIH RoadmapRoadmap InitiativeInitiative MolecularMolecular Libraries Libraries Initiative Initiative 44 Chemical Chemical Synthesis Synthesis MLSCNMLSCN (9+1) (9+1) PubChemPubChem ECCRECCR (6) (6) PredictivePredictive CentersCenters 99 centers centers (NLM)(NLM) ExploratoryExploratory ADMETADMET 11 NIH NIH intramural intramural CentersCenters (8)(8) 100100 x x 10 10 = = 1000 1000 assays assays CombiChemCombiChem ParallelParallel synthesis synthesis DOSDOS NotNot renewed renewed 44 centers centers + + DPI DPI 100k–500k100k–500k compounds compounds SAR matrix ~300,000 compounds Note: Subject http://nihroadmap.nih.gov The University of New Mexico > 1000 assays to change SCHOOL OF MEDICINE NMNM MLSCMLSC (3(3--yearyear summary)summary) U54MH074425U54MH074425 • 23 primary targets (62 assays) uploaded to PubChem • 38 targets total pipeline • ~ 2.4 million datapoints loaded into PubChem • Current throughput: 150,000 samples/week • first 6-plex (small GTP-ases) of the Roadmap • 2nd 6-plex (Bcl-2) also completed
    [Show full text]
  • Sterols As Dietary Markers for Drosophila Melanogaster
    bioRxiv preprint doi: https://doi.org/10.1101/857664; this version posted November 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Sterols as dietary markers for Drosophila melanogaster 2 3 Oskar Knittelfelder1, Elodie Prince2, Susanne Sales1,3, Eric Fritzsche4, Thomas Wöhner4, 4 Marko Brankatschk2, and Andrej Shevchenko1,5 5 6 1MPI of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, 7 Germany 8 2Biotechnologisches Zentrum, Technische Universität Dresden, Tatzberg 47/49, 01309 9 Dresden, Germany 10 3Present address: Thermo Fischer Scientific GmbH, 63303 Dreieich, Germany 11 4Julius Kühn Institut, Pillnitzer Platz 3a, 01326 Dresden, Germany 12 5corresponding author: [email protected] 13 14 ORCID 15 Oskar Knittelfelder: 0000-0002-1565-7238 16 Marko Brankatschk: 0000-0001-5274-4552 17 Andrej Shevchenko: 0000-0002-5079-1109 18 19 Author contributions 20 Experiments design: OK, EP, MB, AS; methods development: OK, SS; experimental work: 21 OK, EP; materials and reagents: EF, TW; data analysis: OK; data interpretation: OK, EP, MB, 22 AS; manuscript preparation: OK, EP, MB, AS; funding: MB, AS 23 24 25 1 bioRxiv preprint doi: https://doi.org/10.1101/857664; this version posted November 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
    [Show full text]
  • Three-Dimensional Structure of Holo 3A,20J3-Hydroxysteroid
    Proc. Nati. Acad. Sci. USA Vol. 88, pp. 10064-10068, November 1991 Biochemistry Three-dimensional structure of holo 3a,20j3-hydroxysteroid dehydrogenase: A member of a short-chain dehydrogenase family (x-ray crystaflography/steroid-metabolizing enzyme/dinucleotide-linked oxldoreductase/sterold-protein interaction/sequence and folding homologies) DEBASHIS GHOSH*t, CHARLES M. WEEKS*, PAWEL GROCHULSKI*t, WILLIAM L. DUAX*, MARY ERMAN*, ROBERT L. RIMSAY§, AND J. C. ORR§ *Medical Foundation of Buffalo, 73 High Street, Buffalo, NY 14203; and Memorial University of Newfoundland, St. John's, Newfoundland, Canada AlB 3V6 Communicated by Herbert A. Hauptman, July 18, 1991 (receivedfor review May 14, 1991) ABSTRACT The x-ray structure of a short-chain dehy- the substrate binding regions, offers further insight concern- drogenase, the bacterial holo 3a,20/3-hydroxysteroid dehydro- ing the significance of conserved residues and their possible genase (EC 1.1.1.53), is described at 2.6 A resolution. This roles in substrate specificity and overall enzyme function. enzyme is active as a tetramer and crystallizes with four identical subunits in the asymmetric unit. It has the a/( fold characteristic ofthe dinucleotide binding region. The fold ofthe MATERIALS AND METHODS rest of the subunit, the quarternary structure, and the nature The crystals, grown in the presence of 4 mM NADH, belong ofthe cofactor-enzyme interactions are, however, significantly to the space group P43212 having unit cell dimensions a = different from those observed in the long-chain dehydrogena- 106.2 A and c = 203.8 A and contain one full tetramer (106 ses. The architecture of the postulated active site is consistent kDa) in the asymmetric unit (13).
    [Show full text]
  • ATP-Citrate Lyase Has an Essential Role in Cytosolic Acetyl-Coa Production in Arabidopsis Beth Leann Fatland Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2002 ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis Beth LeAnn Fatland Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Molecular Biology Commons, and the Plant Sciences Commons Recommended Citation Fatland, Beth LeAnn, "ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis " (2002). Retrospective Theses and Dissertations. 1218. https://lib.dr.iastate.edu/rtd/1218 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis by Beth LeAnn Fatland A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Plant Physiology Program of Study Committee: Eve Syrkin Wurtele (Major Professor) James Colbert Harry Homer Basil Nikolau Martin Spalding Iowa State University Ames, Iowa 2002 UMI Number: 3158393 INFORMATION TO USERS The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleed-through, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted.
    [Show full text]
  • • Our Bodies Make All the Cholesterol We Need. • 85 % of Our Blood
    • Our bodies make all the cholesterol we need. • 85 % of our blood cholesterol level is endogenous • 15 % = dietary from meat, poultry, fish, seafood and dairy products. • It's possible for some people to eat foods high in cholesterol and still have low blood cholesterol levels. • Likewise, it's possible to eat foods low in cholesterol and have a high blood cholesterol level SYNTHESIS OF CHOLESTEROL • LOCATION • All tissues • Liver • Cortex of adrenal gland • Gonads • Smooth endoplasmic reticulum Cholesterol biosynthesis and degradation • Diet: only found in animal fat • Biosynthesis: primarily synthesized in the liver from acetyl-coA; biosynthesis is inhibited by LDL uptake • Degradation: only occurs in the liver • Cholesterol is only synthesized by animals • Although de novo synthesis of cholesterol occurs in/ by almost all tissues in humans, the capacity is greatest in liver, intestine, adrenal cortex, and reproductive tissues, including ovaries, testes, and placenta. • Most de novo synthesis occurs in the liver, where cholesterol is synthesized from acetyl-CoA in the cytoplasm. • Biosynthesis in the liver accounts for approximately 10%, and in the intestines approximately 15%, of the amount produced each day. • Since cholesterol is not synthesized in plants; vegetables & fruits play a major role in low cholesterol diets. • As previously mentioned, cholesterol biosynthesis is necessary for membrane synthesis, and as a precursor for steroid synthesis including steroid hormone and vitamin D production, and bile acid synthesis, in the liver. • Slightly less than half of the cholesterol in the body derives from biosynthesis de novo. • Most cells derive their cholesterol from LDL or HDL, but some cholesterol may be synthesize: de novo.
    [Show full text]
  • Ligands of Therapeutic Utility for the Liver X Receptors
    molecules Review Ligands of Therapeutic Utility for the Liver X Receptors Rajesh Komati, Dominick Spadoni, Shilong Zheng, Jayalakshmi Sridhar, Kevin E. Riley and Guangdi Wang * Department of Chemistry and RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA; [email protected] (R.K.); [email protected] (D.S.); [email protected] (S.Z.); [email protected] (J.S.); [email protected] (K.E.R.) * Correspondence: [email protected] Academic Editor: Derek J. McPhee Received: 31 October 2016; Accepted: 30 December 2016; Published: 5 January 2017 Abstract: Liver X receptors (LXRs) have been increasingly recognized as a potential therapeutic target to treat pathological conditions ranging from vascular and metabolic diseases, neurological degeneration, to cancers that are driven by lipid metabolism. Amidst intensifying efforts to discover ligands that act through LXRs to achieve the sought-after pharmacological outcomes, several lead compounds are already being tested in clinical trials for a variety of disease interventions. While more potent and selective LXR ligands continue to emerge from screening of small molecule libraries, rational design, and empirical medicinal chemistry approaches, challenges remain in minimizing undesirable effects of LXR activation on lipid metabolism. This review provides a summary of known endogenous, naturally occurring, and synthetic ligands. The review also offers considerations from a molecular modeling perspective with which to design more specific LXRβ ligands based on the interaction energies of ligands and the important amino acid residues in the LXRβ ligand binding domain. Keywords: liver X receptors; LXRα; LXRβ specific ligands; atherosclerosis; diabetes; Alzheimer’s disease; cancer; lipid metabolism; molecular modeling; interaction energy 1.
    [Show full text]
  • Genetic Deletion of Abcc6 Disturbs Cholesterol Homeostasis in Mice Bettina Ibold1, Janina Tiemann1, Isabel Faust1, Uta Ceglarek2, Julia Dittrich2, Theo G
    www.nature.com/scientificreports OPEN Genetic deletion of Abcc6 disturbs cholesterol homeostasis in mice Bettina Ibold1, Janina Tiemann1, Isabel Faust1, Uta Ceglarek2, Julia Dittrich2, Theo G. M. F. Gorgels3,4, Arthur A. B. Bergen4,5, Olivier Vanakker6, Matthias Van Gils6, Cornelius Knabbe1 & Doris Hendig1* Genetic studies link adenosine triphosphate-binding cassette transporter C6 (ABCC6) mutations to pseudoxanthoma elasticum (PXE). ABCC6 sequence variations are correlated with altered HDL cholesterol levels and an elevated risk of coronary artery diseases. However, the role of ABCC6 in cholesterol homeostasis is not widely known. Here, we report reduced serum cholesterol and phytosterol levels in Abcc6-defcient mice, indicating an impaired sterol absorption. Ratios of cholesterol precursors to cholesterol were increased, confrmed by upregulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase (Hmgcr) expression, suggesting activation of cholesterol biosynthesis in Abcc6−/− mice. We found that cholesterol depletion was accompanied by a substantial decrease in HDL cholesterol mediated by lowered ApoA-I and ApoA-II protein levels and not by inhibited lecithin-cholesterol transferase activity. Additionally, higher proprotein convertase subtilisin/kexin type 9 (Pcsk9) serum levels in Abcc6−/− mice and PXE patients and elevated ApoB level in knockout mice were observed, suggesting a potentially altered very low-density lipoprotein synthesis. Our results underline the role of Abcc6 in cholesterol homeostasis and indicate impaired cholesterol metabolism as an important pathomechanism involved in PXE manifestation. Mutations in the adenosine triphosphate-binding cassette transporter C6 (ABCC6) gene are responsible for pseudoxanthoma elasticum (PXE), a metabolic disease, hallmarked by a progressive elastic fber calcifcation of the skin, eyes and cardiovascular system.
    [Show full text]
  • Drug Resistance Updates 32 (2017) 23–46
    Drug Resistance Updates 32 (2017) 23–46 Contents lists available at ScienceDirect Drug Resistance Updates journal homepage: www.elsevier.com/locate/drup Not only P-glycoprotein: Amplification of the ABCB1-containing MARK chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins ⁎ ⁎ Ilaria Genovesea,1, Andrea Ilarib,1, Yehuda G. Assarafc,1, Francesco Fazid, ,1, Gianni Colottib, ,1 a Dept. Biochemical Sciences, Sapienza University, P.le A. Moro 5, 00185 Rome, Italy b Institute of Molecular Biology and Pathology, Italian National Research Council (IBPM-CNR), c/o Dept. Biochemical Sciences, Sapienza University, P.le A. Moro 5, 00185 Rome, Italy c The Fred Wyszkowski Cancer Research Lab, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel d Dept. Anatomical, Histological, Forensic & Orthopedic Sciences, Section of Histology and Medical Embryology, Sapienza University, Via A. Scarpa 14-16, 00161 Rome, Italy ARTICLE INFO ABSTRACT Keywords: The development of drug resistance continues to be a dominant hindrance toward curative cancer treatment. ABC transporters Overexpression of a wide-spectrum of ATP-dependent efflux pumps, and in particular of ABCB1 (P-glycoprotein P-glycoprotein (P-gp) or MDR1) is a well-known resistance mechanism for a plethora of cancer chemotherapeutics including for ex- Cancer ample taxenes, anthracyclines, Vinca alkaloids, and epipodopyllotoxins, demonstrated by a large array of pub- Chemotherapeutic drugs lished papers, both in tumor cell lines and in a variety of tumors, including various solid tumors and hemato- Multidrug resistance logical malignancies. Upon repeated or even single dose treatment of cultured tumor cells or tumors in vivo with 7q21 amplicon Sorcin anti-tumor agents such as paclitaxel and doxorubicin, increased ABCB1 copy number has been demonstrated, resulting from chromosomal amplification events at 7q11.2-21 locus, leading to marked P-glycoprotein over- expression, and multidrug resistance (MDR).
    [Show full text]
  • 1970Qureshiocr.Pdf (10.44Mb)
    STUDY INVOLVING METABOLISM OF 17-KETOSTEROIDS AND 17-HYDROXYCORTICOSTEROIDS OF HEALTHY YOUNG MEN DURING AMBULATION AND RECUMBENCY A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN NUTRITION IN THE GRADUATE DIVISION OF THE TEXAS WOI\IIAN 'S UNIVERSITY COLLEGE OF HOUSEHOLD ARTS AND SCIENCES BY SANOBER QURESHI I B .Sc. I M.S. DENTON I TEXAS MAY I 1970 ACKNOWLEDGMENTS The author wishes to express her sincere gratitude to those who assisted her with her research problem and with the preparation of this dissertation. To Dr. Pauline Beery Mack, Director of the Texas Woman's University Research Institute, for her invaluable assistance and gui­ dance during the author's entire graduate program, and for help in the preparation of this dissertation; To the National Aeronautics and Space Administration for their support of the research project of which the author's study is a part; To Dr. Elsa A. Dozier for directing the author's s tucly during 1969, and to Dr. Kathryn Montgomery beginning in early 1970, for serving as the immeclia te director of the author while she was working on the completion of the investic;ation and the preparation of this dis- sertation; To Dr. Jessie Bateman, Dean of the College of Household Arts and Sciences, for her assistance in all aspects of the author's graduate program; iii To Dr. Ralph Pyke and Mr. Walter Gilchrist 1 for their ass is­ tance and generous kindness while the author's research program was in progress; To Mr. Eugene Van Hooser 1 for help during various parts of her research program; To Dr.
    [Show full text]
  • The Effects of Exogenous ACTH on 5-3B-Hydroxysteroid Dehydrogenase Activity in the Embryonic Avian Adrenal Gland
    Loyola University Chicago Loyola eCommons Master's Theses Theses and Dissertations 1968 The Effects of Exogenous ACTH on 5-3b-hydroxysteroid Dehydrogenase Activity in the Embryonic Avian Adrenal Gland Grover Charles Ericson Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_theses Part of the Medicine and Health Sciences Commons Recommended Citation Ericson, Grover Charles, "The Effects of Exogenous ACTH on 5-3b-hydroxysteroid Dehydrogenase Activity in the Embryonic Avian Adrenal Gland" (1968). Master's Theses. 2264. https://ecommons.luc.edu/luc_theses/2264 This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 1968 Grover Charles Ericson THE EFFECTS OF EXOGENOUS ACTH ON d -JB-HYDROXYSTEROID DEHYDROGENASE ACTIVITY IN THE EMBRYONIC AVIAN ADRENAL GLAND by Grover Charles Ericson A The.is Submitted to the Faculty ot the Graduate School of La.vo1. University in Partial Fulfillment ot the Requirements for the Degree ot Master ot Science February 1968 BIOGRAPHY Grover Charles Ericson was born in Oak Park, D.linois, on February 17. 1941. He •• graduated f'rom the Naperville COIIUlIW1ity High School, Naperville. D.l1nois in June, 19.59. He entered North Central College, Naperville. Illinois, in September, 19.59, and was awarded the Bachelor of Arts degree in June, 1964. While attending North Central College.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,906,307 B2 S0e Et Al
    US007906307B2 (12) United States Patent (10) Patent No.: US 7,906,307 B2 S0e et al. (45) Date of Patent: Mar. 15, 2011 (54) VARIANT LIPIDACYLTRANSFERASES AND 4,683.202 A 7, 1987 Mullis METHODS OF MAKING 4,689,297 A 8, 1987 Good 4,707,291 A 11, 1987 Thom 4,707,364 A 11/1987 Barach (75) Inventors: Jorn Borch Soe, Tilst (DK); Jorn 4,708,876 A 1 1/1987 Yokoyama Dalgaard Mikkelson, Hvidovre (DK); 4,798,793 A 1/1989 Eigtved 4,808,417 A 2f1989 Masuda Arno de Kreij. Geneve (CH) 4,810,414 A 3/1989 Huge-Jensen 4,814,331 A 3, 1989 Kerkenaar (73) Assignee: Danisco A/S, Copenhagen (DK) 4,818,695 A 4/1989 Eigtved 4,826,767 A 5/1989 Hansen 4,865,866 A 9, 1989 Moore (*) Notice: Subject to any disclaimer, the term of this 4,904.483. A 2f1990 Christensen patent is extended or adjusted under 35 4,916,064 A 4, 1990 Derez U.S.C. 154(b) by 0 days. 5,112,624 A 5/1992 Johna 5,213,968 A 5, 1993 Castle 5,219,733 A 6/1993 Myojo (21) Appl. No.: 11/852,274 5,219,744 A 6/1993 Kurashige 5,232,846 A 8, 1993 Takeda (22) Filed: Sep. 7, 2007 5,264,367 A 11/1993 Aalrust (Continued) (65) Prior Publication Data US 2008/OO70287 A1 Mar. 20, 2008 FOREIGN PATENT DOCUMENTS AR 331094 2, 1995 Related U.S. Application Data (Continued) (63) Continuation-in-part of application No.
    [Show full text]
  • A Squalene–Hopene Cyclase in Schizosaccharomyces Japonicus Represents a Eukaryotic Adaptation to Sterol-Limited Anaerobic Environments
    A squalene–hopene cyclase in Schizosaccharomyces japonicus represents a eukaryotic adaptation to sterol-limited anaerobic environments Jonna Bouwknegta,1, Sanne J. Wiersmaa,1, Raúl A. Ortiz-Merinoa, Eline S. R. Doornenbala, Petrik Buitenhuisa, Martin Gierab, Christoph Müllerc, and Jack T. Pronka,2 aDepartment of Biotechnology, Delft University of Technology, 2629 HZ Delft, The Netherlands; bCenter for Proteomics and Metabolomics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; and cDepartment of Pharmacy, Center for Drug Research, Ludwig-Maximillians University Munich, 81377 Munich, Germany Edited by Roger Summons, Massachusetts Institute of Technology, Cambridge, MA, and approved July 6, 2021 (received for review March 18, 2021) Biosynthesis of sterols, which are key constituents of canonical and acquisition of a bacterial STC gene by horizontal gene transfer is eukaryotic membranes, requires molecular oxygen. Anaerobic protists considered a key evolutionary adaptation of Neocalllimastigomycetes and deep-branching anaerobic fungi are the only eukaryotes in which to the strictly anaerobic conditions of the gut of large herbivores a mechanism for sterol-independent growth has been elucidated. In (7). The reaction catalyzed by STC resembles oxygen-independent these organisms, tetrahymanol, formed through oxygen-independent conversion of squalene to hopanol and/or other hopanoids by cyclization of squalene by a squalene–tetrahymanol cyclase, acts as a squalene–hopene cyclases (8) (SHC; SI Appendix,Fig.S1), which sterol surrogate. This study confirms an early report [C. J. E. A. Bulder, are found in many bacteria (9, 10). Some bacteria synthesize tet- Antonie Van Leeuwenhoek,37,353–358 (1971)] that Schizosaccharo- rahymanol by ring expansion of hopanol, in a reaction catalyzed by myces japonicus is exceptional among yeasts in growing anaerobi- tetrahymanol synthase (THS) for which the precise mechanism cally on synthetic media lacking sterols and unsaturated fatty acids.
    [Show full text]